1. Home
  2. KO vs MRK Comparison

KO vs MRK Comparison

Compare KO & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coca-Cola Company (The)

KO

Coca-Cola Company (The)

HOLD

Current Price

$70.58

Market Cap

296.4B

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$100.27

Market Cap

260.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KO
MRK
Founded
1886
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
296.4B
260.2B
IPO Year
1919
N/A

Fundamental Metrics

Financial Performance
Metric
KO
MRK
Price
$70.58
$100.27
Analyst Decision
Strong Buy
Buy
Analyst Count
13
15
Target Price
$78.15
$109.13
AVG Volume (30 Days)
17.7M
15.8M
Earning Date
10-21-2025
10-30-2025
Dividend Yield
2.89%
3.39%
EPS Growth
25.34
58.08
EPS
3.02
7.56
Revenue
$47,663,000,000.00
$64,235,000,000.00
Revenue This Year
$5.66
$1.97
Revenue Next Year
$5.00
$4.96
P/E Ratio
$23.35
$13.27
Revenue Growth
2.80
1.68
52 Week Low
$60.62
$73.31
52 Week High
$74.38
$105.84

Technical Indicators

Market Signals
Indicator
KO
MRK
Relative Strength Index (RSI) 50.32 59.78
Support Level $68.79 $96.06
Resistance Level $70.69 $99.85
Average True Range (ATR) 1.03 2.46
MACD -0.31 -0.70
Stochastic Oscillator 40.20 43.03

Price Performance

Historical Comparison
KO
MRK

About KO Coca-Cola Company (The)

Founded in 1886, Atlanta-headquartered Coca-Cola is the world's largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: